SCHEMBL21453344

SCHEMBL21453344

O=c1c2ccc(N3c4ccccc4[Si]4(c5ccccc5N(c5ccccc5)c5ccccc54)c4ccccc43)cc2oc2ccncc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.38
CYP11B1 P15538 3/20 0.36
CYP11B2 P19099 3/20 0.36
CYP19A1 P11511 3/20 0.36
TTR P02766 1/20 0.35
MAOA P21397 3/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 2/20 0.33
ATM Q13315 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GLA P06280 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
PGAM1 P18669 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21453615 0.88 PTGER4 (0.47) PTGER4CYP11B1CYP11B2CYP19A1TTR
SCHEMBL21453345 0.85 ALDH1A1 (0.39) PTGER4CYP11B1CYP11B2CYP19A1TTR
SCHEMBL19319612 0.77 PTGER4 (0.48) PTGER4TTRMAOATDP1NPC1
SCHEMBL19318085 0.74 PTGER4 (0.46) PTGER4TTRMAOATDP1NPC1
SCHEMBL21453612 0.71 PTGER4 (0.47) PTGER4CYP11B1CYP11B2CYP19A1TTR
SCHEMBL21453422 0.71 MAOA (0.46) MAOAKDM4EALDH1A1SMN1; SMN2CYP3A4
SCHEMBL21484551 0.70 CYP19A1 (0.40) PTGER4CYP11B1CYP11B2CYP19A1TTR
SCHEMBL21479692 0.70 CYP19A1 (0.40) PTGER4CYP11B1CYP11B2CYP19A1TTR
SCHEMBL2879978 0.70 MAOA (0.67) CYP11B1CYP11B2CYP19A1TTRMAOA
SCHEMBL19319643 0.70 CHRNA7 (0.50) PTGER4TTRMAOANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190312210-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190312210-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLCO4C1, SLCO2A1, SLCO1A2 PTGER4 2858/4885CYP11B1 630/4885CYP11B2 926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.